BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5982822)

  • 1. [Ceruloplasmin and copper metabolism in multiple sclerosis].
    Bammer H
    Dtsch Z Nervenheilkd; 1966 Oct; 189(4):312-29. PubMed ID: 5982822
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of serum and cerebrospinal fluid ceruloplasmin in multiple sclerosis and other neurologic diseases.
    Becuş T; Popoviciu L; Palade C
    Rev Roum Neurol; 1971; 8(1):3-13. PubMed ID: 5563146
    [No Abstract]   [Full Text] [Related]  

  • 3. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.
    De Riccardis L; Buccolieri A; Muci M; Pitotti E; De Robertis F; Trianni G; Manno D; Maffia M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1828-1838. PubMed ID: 29524632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nervous system diseases and proteins in the blood and cerebrospinal fluid].
    Ito H; Miura S
    Saishin Igaku; 1968 Aug; 23(8):1651-61. PubMed ID: 4883043
    [No Abstract]   [Full Text] [Related]  

  • 5. Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders.
    Kapaki E; Segditsa J; Papageorgiou C
    Acta Neurol Scand; 1989 May; 79(5):373-8. PubMed ID: 2545071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of 2 -HS, ceruloplasmin, - 1A - 1C , hemopexin and IgA].
    Schuller E; Allinquant B; Garcia M; Lefèvre M; Moreno P; Tompe L
    Clin Chim Acta; 1971 Jun; 33(1):5-11. PubMed ID: 4106481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophoresis of cerebrospinal fluid proteins].
    Schuller E
    Nouv Presse Med; 1979 Mar; 8(10):785. PubMed ID: 461129
    [No Abstract]   [Full Text] [Related]  

  • 8. [The clinical characteristics and differential diagnosis of hyperkinetic forms of multiple sclerosis].
    Chernigovskaia NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):23-7. PubMed ID: 5425793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 11. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum and cerebrospinal fluid copper levels in patients with multiple sclerosis based on emission spectral analysis findings].
    Kravtsova AF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):213-6. PubMed ID: 5590869
    [No Abstract]   [Full Text] [Related]  

  • 14. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitation of plasma proteins in cerebrospinal fluid.
    Bock E
    Scand J Immunol Suppl; 1973; 1():111-7. PubMed ID: 4773069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Copper and zinc in cerebrospinal fluid of children with neurological diseases (author's transl)].
    Kotlarek F; Berg W
    Monatsschr Kinderheilkd (1902); 1978 Dec; 126(12):718-21. PubMed ID: 732823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of serum fatty acids in neurological diseases.
    Kalofoutis A; Jullien G
    Biochimie; 1974; 56(4):623-4. PubMed ID: 4425039
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing serum ceruloplasmin levels in normal individuals.
    Cox DW
    J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microzone electrophoresis of the nonconcentrated cerebrospinal fluid in nervous system diseases].
    Glasner H; Schmidt LR
    Nervenarzt; 1976 Nov; 47(11):675-81. PubMed ID: 63922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.